- Home
- EHC vs RVTY Comparison
EHC vs RVTY Comparison
Compare EHC & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EHC | RVTY |
|---|---|---|
| Founded | 1983 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5B | 11.8B |
| IPO Year | 1986 | N/A |
Fundamental Metrics
Financial Performance| Metric | EHC | RVTY |
|---|---|---|
| Price | $111.38 | $102.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 15 |
| Target Price | ★ $143.29 | $113.00 |
| AVG Volume (30 Days) | 1.6M | ★ 1.7M |
| Earning Date | 02-05-2026 | 02-02-2026 |
| Dividend Yield | ★ 0.70% | 0.27% |
| EPS Growth | ★ 24.25 | N/A |
| EPS | ★ 5.54 | 2.07 |
| Revenue | ★ $5,935,200,000.00 | $2,856,051,000.00 |
| Revenue This Year | $9.82 | $6.06 |
| Revenue Next Year | $8.15 | $5.15 |
| P/E Ratio | ★ $19.64 | $50.64 |
| Revenue Growth | ★ 10.46 | 3.67 |
| 52 Week Low | $92.53 | $81.36 |
| 52 Week High | $127.99 | $120.39 |
Technical Indicators
Market Signals| Indicator | EHC | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 71.52 | 44.84 |
| Support Level | $92.77 | $98.89 |
| Resistance Level | $115.71 | $106.55 |
| Average True Range (ATR) | 3.54 | 4.06 |
| MACD | 2.12 | -1.26 |
| Stochastic Oscillator | 81.60 | 19.57 |
Price Performance
Historical ComparisonAbout EHC Encompass Health Corporation
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.
About RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.